Age category, years | Non-compaction n (%) | ASD n (%) | AVCD n (%) | PDA n (%) | Congenital PS n (%) | Dextrocardia n (%) | ToF n (%) | HCMP n (%) | Myxoma n (%) | TGA n (%) | VSD n (%) | Subaortic membrane n (%) | Percentage among CHDs, n (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0–15 | 0 (0) | 25 (2.2) | 5 (0.4) | 23 (2.0) | 7 (0.6) | 0 (0) | 15 (1.3) | 0 (0) | 0 (0) | 8 (0.7) | 18 (1.6) | 1 (0.1) | 102 (67.5) |
16–30 | 1 (0.1) | 8 (0.7) | 1 (0.1) | 2 (0.2) | 3 (0.3) | 0 (0) | 4 (0.4) | 4 (0.4) | 0 (0) | 0 (0) | 5 (0.4) | 1 (0.1) | 29 (19.2) |
31–45 | 0 (0) | 1 (0.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.1) | 1 (0.1) | 1 (0.1) | 0 (0) | 2 (0.2) | 0 (0) | 6 (4.0) |
46–60 | 3 (0.3) | 2 (0.2) | 0 (0) | 0 (0) | 0 (0) | 1 (0.1) | 0 (0) | 4 (0.4) | 1 (0.1) | 0 (0) | 1 (0.1) | 0 (0) | 12 (7.9) |
61–75 | 1 (0.1) | 1 (0.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (1.3) |
+ 75 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Percentage among the study population | 5 (0.4) | 37 (3.2) | 6 (0.5) | 25 (2.2) | 10 (0.9) | 1 (0.1) | 20 (1.8) | 9 (0.8) | 2 (0.2) | 8 (0.7) | 26 (2.3) | 2 (0.2) |